FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Duato Joaquin

2. Date of Event Requiring Statement (MM/DD/YYYY)
4/28/2016 

3. Issuer Name and Ticker or Trading Symbol

JOHNSON & JOHNSON [JNJ]

(Last)        (First)        (Middle)

ONE JOHNSON & JOHNSON PLAZA

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Exec VP, WW Chair, Pharma /

(Street)

NEW BRUNSWICK, NJ 08933       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   47960.0000   D    
Common Stock   538.0000   (1) I   By 401k  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options (Right to Buy)   (2) 2/10/2012   2/8/2019   Common Stock   34288.0000   $58.3300   D    
Employee Stock Options (Right to Buy)   (2) 2/12/2011   2/10/2018   Common Stock   20842.0000   $61.7500   D    
Employee Stock Options (Right to Buy)   (2) 1/11/2014   1/8/2021   Common Stock   19293.0000   $62.2000   D    
Employee Stock Options (Right to Buy)   (2) 1/18/2015   1/17/2022   Common Stock   100000.0000   $65.3700   D    
Employee Stock Options (Right to Buy)   (2) 1/17/2016   1/13/2023   Common Stock   148538.0000   $72.5400   D    
Employee Stock Options (Right to Buy)   (2) 2/11/2017   2/9/2024   Common Stock   130969.0000   $90.4400   D    
Employee Stock Options (Right to Buy)   (2) 2/10/2018   2/9/2025   Common Stock   126369.0000   $100.0600   D    
Employee Stock Options (Right to Buy)   (2) 2/9/2019   2/8/2026   Common Stock   125824.0000   $101.8700   D    
Restricted Share Units   (3) 2/8/2019     (3) Common Stock   9049.0000     (3) D    
Restricted Share Units   (3) 2/9/2018     (3) Common Stock   9812.0000     (3) D    
Restricted Share Units   (3) 2/10/2017     (3) Common Stock   8919.0000     (3) D    

Explanation of Responses:
( 1)  Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan.
( 2)  Vested and exercisable one day after the third anniversary of the date of the grant.
( 3)  Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.

Remarks:
duatopoa.txt

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Duato Joaquin
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933

Exec VP, WW Chair, Pharma

Signatures
Linda E. King, as attorney-in-fact for Joaquin Duato 5/5/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Johnson and Johnson Charts.